Calcium Channel Antagonists in the Treatment of Asthma

References

• Triggle D J, Swamy V C. Pharmacology of agents that affect calcium. Chest 1980; 78(Suppl))174
   Google Scholar
• Melville K I, Benfey B G. Coronary vasodilatory and cardiac adrenergic blocking effects of iproveratril. Can J Pharmacol 1965; 43: 339
   Google Scholar
• Hills E A. Iproveratril and bronchial asthma. Br J Clin Pract 1970; 24: 116
   Google Scholar
• Ringqvist T. Effect of verapamil on obstructive airways disease. Eur J Clin Pharmacol 1974; 7: 61
   Google Scholar
• Triggle D J. Calcium antagonists: Basic chemical and pharmacological aspects. New Perspectives on Calcium Antagonists, G B Weiss. American Physiological Society, Bethesda, MD 1981; 1–18
   Google Scholar
• Mitchell L B, Schroeder J S, Mason J W. Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: A review. Am J Cardiol 1982; 49: 629
   Google Scholar
• Altura B M, Altura B T, Gebrewold A. Comparative microvascular actions of Ca2+ antagonists. Ca²⁺ Entry Blockers, Adenosine and Neurohumors, G F Merrill, H R Weiss. Urban and Schwarzenberg, Baltimore 1983; 155–175
   Google Scholar
• Fanta C H, Venugopalan C S, Lacouture P G, Drazen J M. Inhibition of bronchoconstriction in the guinea pig by a calcium channel blocker, nifedipine. Am Rev Respir Dis 1982; 125: 61
   PubMed Web of Science ®Google Scholar
• Himori N, Taira N. Differential effects of the calcium-antagonistic vasodilators, nifedipine and verapamil, on the tracheal musculature and vasculature of the dog. Br J Pharmacol 1980; 68: 595
   Google Scholar
• Henderson A F, Heaton R W, Dunlop L S, Costello J F. Effects of nifedipine on antigen-induced bronchoconstriction. Am Rev Respir Dis 1983; 127: 549
   PubMed Web of Science ®Google Scholar
• Coburn R F. The airway smooth muscle cell. Fed Proc 1977; 36: 2692
   Google Scholar
• Farley J M, Miles P R. The sources of calcium for acetylcholine-induced contractions of dog tracheal smooth muscle. J Pharmacol Exp Ther 1978; 207: 340
   PubMed Web of Science ®Google Scholar
• Brugman T M, Darness M L, Hirshman C A. Nifedipine aerosol attenuates airway constriction in dogs with hyperreactive airways. Am Rev Respir Dis 1983; 127: 14
   Google Scholar
• Malo P E, Wasserman M A, Griffin R L. Effects of intravenous and aerosol nifedipine on prostaglandin F2β and histamine-induced bronchoconstriction in anesthetized dogs. J Pharmacol Exp Ther 1982; 221: 410
   Google Scholar
• Russi E W, Yerger B M, Abraham W M, Ahmed T. Modification of allergic bronchoconstriction by a calcium antagonist: Mode of action. Am Rev Respir Dis 1983; 127: 675
   PubMed Web of Science ®Google Scholar
• Middleton E, Drzewiecki G, Triggle D. Effects of smooth muscle calcium antagonists on human basophil histamine release. Biochem Pharmacol 1981; 30: 2867
   Google Scholar
• Bedard R M, Busse W W. Nifedipine inhibition of human basophil histamine release (HR). J Allergy Clin Immunol 1983; 71: 104, (abstract)
   Google Scholar
• Swenson C A, Dick E, Busse W. Influenza A virus enhanced basophilic leukocyte histamine release: A calcium flux defect. J Allergy Clin Immunol 1984; 73: 165, (abstract)
   Google Scholar
• Putney J W. Stimulus-permeability coupling: Role of calcium in the receptor regulation of membrane permeability. Pharmacol Rev 1978; 30: 209
   PubMed Web of Science ®Google Scholar
• Putney J W, Parod R J, Marier S H. Control by calcium of exocytosis and membrane permeability to potassium in the rat lacrimal gland. Life Sci 1977; 20: 1905
   PubMedGoogle Scholar
• Marier S H, Putney J W, Vande Walle C M. Control of calcium channels by membrane receptors in the rat parotid gland. J Physiol London 1978; 279: 141
   Google Scholar
• Cerrina J, Denjean A, Alexandre G, Lockhart A, Duroux P. Inhibition of exercise-induced asthma by a calcium antagonist, nifedipine. Am Rev Respir Dis 1981; 123: 156
   PubMed Web of Science ®Google Scholar
• Barnes P J, Wilson N M, Brown M J. A calcium antagonist, nifedipine, modifies exercise-induced asthma. Thorax 1981; 36: 726
   PubMed Web of Science ®Google Scholar
• Patel K R. The effect of calcium antagonist, nifedipine in exercise-induced asthma. Clin Allergy 1981; 11: 429
   PubMedGoogle Scholar
• Henderson A F, Heaton R W, Costello J F. Effect of nifedipine on bronchoconstriction induced by inhalation of cold air. Thorax 1983; 38: 512
   PubMedGoogle Scholar
• Williams D O, Barnes P J, Vickers H P, Rudolf M. Effect of nifedipine on bronchomotor tone and histamine reactivity in asthma. Br Med J 1981; 283: 348
   PubMed Web of Science ®Google Scholar
• Gonzalez J M, Morice R C, Bloom K, Akers S, Raizner A E, Stevens P M. Inhibition of airway reactivity by nifedipine in patients with coronary artery disease. Am Rev Respir Dis 1983; 127: 155
   PubMed Web of Science ®Google Scholar
• Nair N, Bewtra A, Townley R, Nair C. Safety of nifedipine in asthma and chronic obstructive lung disease. J Allergy Clin Immunol 1983; 72: 149, (abstract)
   Google Scholar
• Patakas D, Vlachoianni E, Tsara V, Louridas G, Argiropoulou P. Nifedipine in bronchial asthma. J Allergy Clin Immunol 1983; 72: 269
   PubMed Web of Science ®Google Scholar
• Patel K R. Calcium antagonists in exercise-induced asthma. Br Med J 1981; 282: 932
   PubMed Web of Science ®Google Scholar
• Malik S, O'Reilly J, Sudlow M F. Effects of sublingual nifedipine on inhaled histamine and methacholine-induced bronchoconstriction in atopic subjects. Thorax 1982; 32: 230, (abstract)
   Google Scholar
• Patel Al-Shamma K R. Effect of nifedipine on histamine reactivity in asthma. Br Med J 1982; 284: 1916
   Google Scholar
• Patel K R. The effect of verapamil on histamine and methacholine-induced bronchoconstriction. Clin Allergy 1981; 11: 441
   PubMedGoogle Scholar
• Zelis R F, Kinney E L. The pharmacokinetics of diltiazem in healthy American men. Am J Cardiol 1982; 49: 529
   Google Scholar
• Ramsch K. Zur Pharmakokinetik von Nifedipine. Schwerpunkt Med 1981; 4: 4
   Google Scholar
• Koike Y, Shimamura K, Shudo I, Saito H. Pharmacokinetics of verapamil in man. Rev Commun Chem Pathol Pharmacol 1979; 24: 37
   PubMedGoogle Scholar
• Fanta C H, Drazen J M. Calcium blockers and bronchoconstriction. Am Rev Respir Dis 1983; 127: 673
   Google Scholar